SCHEMBL6890546

SCHEMBL6890546

Cc1n[nH]c2c1c(C1CCCCC1)nc1c(-c3cnc4ccccc4c3)cnn12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 4/20 0.38
MTOR P42345 4/20 0.38
PIK3CD O00329 1/20 0.38
ABL1 P00519 1/20 0.38
EGFR P00533 1/20 0.38
HCK P08631 1/20 0.38
SRC P12931 1/20 0.38
KDR P35968 1/20 0.38
PIK3CB P42338 1/20 0.38
PIK3CG P48736 1/20 0.38
EPHB4 P54760 1/20 0.38
PRKDC P78527 1/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
MEN1 O00255 1/20 0.38
NR2F2 P24468 1/20 0.38
KMT2A Q03164 1/20 0.38
CHEK1 O14757 3/20 0.37
CCNA2 P20248 2/20 0.37
CDK2 P24941 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6892192 0.89 PIK3CA (0.38) PIK3CAMTORPIK3CDABL1EGFR
SCHEMBL10328286 0.88 PIK3CA (0.40) PIK3CAMTOREGFRNPC1RAB9A
SCHEMBL6894476 0.80 MTOR (0.34) PIK3CAMTORRPTORMLST8HSP90AA1
SCHEMBL10328276 0.79 KDM4E (0.34) MTORNPC1RAB9AMEN1KMT2A
SCHEMBL10328266 0.78 HSP90AA1 (0.36) PIK3CAMTOREGFRCHEK1CCNA2
SCHEMBL1073784 0.77 HSP90AA1 (0.40) PIK3CAMTORNPC1RAB9AMEN1
SCHEMBL6890317 0.77 PARP10 (0.35) PIK3CAMTORNPC1RAB9AMEN1
SCHEMBL6895952 0.76 CHEK1 (0.53) PIK3CAMTORPIK3CDABL1EGFR
SCHEMBL6894959 0.76 MTOR (0.39) MTORABL1NPC1RAB9AMEN1
SCHEMBL1074944 0.75 MTOR (0.50) MTORKDRNPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002887-A1 FUSED TRICYCLIC COMPOUNDS AS NOVEL mTOR INHIBITORS SCHERING CORPORATION (US) 2011-01-06 WO disclosed